Literature DB >> 2544612

Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo.

D Benayahu1, Y Kletter, D Zipori, S Wientroub.   

Abstract

Marrow stroma has been shown to have osteogenic potential. Here we report the characterization of a unique stromal cell line derived from mouse bone marrow (MBA-15), which expresses osteoblastic phenotype in vitro and forms bone in vivo. More than 70% of cells in culture were histochemically positive for alkaline phosphatase. The enzyme levels were enhanced threefold when cultures were treated with dexamethasone. Gel electrophoresis of [3H]-proline-labeled cultures showed that MBA-15 cells produced only type I collagen. These cells were responsive to PTH, as indicated by a 50-fold increase in intracellular cAMP. Prostaglandin E2, but not calcitonin, stimulated cAMP up to 70-fold. When cultures were grown to confluence and fed daily with ascorbic acid and beta-glycerophosphate, the cells formed a Von Kossa positive, thick extracellular matrix, shown to contain hydroxyapatite crystals. MBA-15 cells produced mineralized bone when implanted in diffusion chambers. These results indicate that the MBA-15 cell line possesses osteoblastic features in vitro and osteogenic capacity in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544612     DOI: 10.1002/jcp.1041400102

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  35 in total

1.  Hemopoietic functions of marrow-derived osteogenic cells.

Authors:  D Benayahu; M Horowitz; D Zipori; S Wientroub
Journal:  Calcif Tissue Int       Date:  1992-09       Impact factor: 4.333

2.  In vivo bone formation by human bone marrow cells: effect of osteogenic culture supplements and cell densities.

Authors:  S C Mendes; I Van Den Brink; J D De Bruijn; C A Van Blitterswijk
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

3.  The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects.

Authors:  A Scutt; P Bertram; M Bräutigam
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

4.  Partial characterization of rat marrow stromal cells.

Authors:  D J Simmons; P Seitz; L Kidder; G L Klein; M Waeltz; C M Gundberg; C Tabuchi; C Yang; R W Zhang
Journal:  Calcif Tissue Int       Date:  1991-05       Impact factor: 4.333

5.  Subpopulations of marrow stromal cells share a variety of osteoblastic markers.

Authors:  D Benayahu; A Fried; D Zipori; S Wientroub
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

6.  Modulation of alkaline phosphatase activity in alveolar type II like cells.

Authors:  M Kalina; D Levi; S Riklis
Journal:  Histochemistry       Date:  1990

7.  Bone-chip system to monitor osteogenic differentiation using optical imaging.

Authors:  Dmitriy Sheyn; Doron Cohn-Yakubovich; Shiran Ben-David; Sandra De Mel; Virginia Chan; Christopher Hinojosa; Norman Wen; Geraldine A Hamilton; Dan Gazit; Zulma Gazit
Journal:  Microfluid Nanofluidics       Date:  2019-07-06       Impact factor: 2.529

Review 8.  Mesenchymal Stem Cell/Multipotent Stromal Cell Augmentation of Wound Healing: Lessons from the Physiology of Matrix and Hypoxia Support.

Authors:  Kyle Sylakowski; Andrew Bradshaw; Alan Wells
Journal:  Am J Pathol       Date:  2020-04-12       Impact factor: 4.307

9.  Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines.

Authors:  Y Engelbrecht; H de Wet; K Horsch; C R Langeveldt; F S Hough; P A Hulley
Journal:  Endocrinology       Date:  2003-02       Impact factor: 4.736

10.  Human bone marrow stromal cells express an osteoblastic phenotype in culture.

Authors:  J Vilamitjana-Amedee; R Bareille; F Rouais; A I Caplan; M F Harmand
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-09       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.